The amelioration of AH by abstinence and the attenuation of oxidative stress

Hepato-Gastroenterology

Volumn 59, Issue 113, 2012, Pages 73-76

  Wang, Tianyi ^a   Zhu, Dong ^a   Xu, Xinpin ^a   Xu, Youqing ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Abstinence; Alcoholic hepatitis; Mechanism; Reactive oxidative stress; Serum biomarkers

Indexed keywords

ALCOHOL; BIOLOGICAL MARKER; GLUTATHIONE; LIVER ENZYME; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ABDOMINAL RADIOGRAPHY; ADULT; AGED; ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ALCOHOL LIVER DISEASE; ARTICLE; ATTENUATION; BLOOD SAMPLING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LIVER; LIVER FIBROSIS; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SERUM; SPLEEN;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHINA; FATTY LIVER, ALCOHOLIC; GLUTATHIONE; HEPATITIS, ALCOHOLIC; HUMANS; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; SPLEEN; SUPEROXIDE DISMUTASE; TEMPERANCE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84863239107     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11259     Document Type: Article

References (18)

1. Mandayam S, Jamal MM, Morgan TR: Epidemiology of alcoholic liver disease. Semin Liver Dis 2004; 24:217-32. (Pubitemid 39167681)
2. Li YM: Current researches of alcoholic liver disease in China. Modern Digestion & Intervention 2007; 12(4):235.
3. Haber PS, Warner R, Seth D, Gorrell MD, McCaughan GW: Pathogenesis and management of alcoholic hepatitis. J Gastroenterol Hepatol 2003; 18:1332-1344. (Pubitemid 38045845)
4. Kulkarni K, Tran T, Medrano M, Yoffe B, Goodgame R: The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis. J Clin Gastroenterol 2004; 38:453-459.
5. Albano E: Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol Aspects Med 2008; 29:9-16.
6. Seth D, Gorrell MD, Cordoba S, McCaughan GW, Haber PS: Intrahepatic gene expressio in human alcoholic hepatitis. J Hepatol 2006; 45:306-320.
7. O'Shea RS. Dasarathy S, McCullough A, et al.: Alcoholic liver disease. Hepatol 2010; 51(1):307-328.
8. Chrostek L, Cylwik B, Szmitkowski M, Korcz W: The diagnostic accuracy of carbohydrate-deficient transferrin, sialic acid and commonly used markers of alcohol abuse during abstinence. Clin Chim Acta 2006; 364:167-171. (Pubitemid 43120637)
9. Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, Helander A, Tabakoff B; WHO/ISBRA Study Group: CDT GGT, and AST as markers of alcohol use: The WHO/ISBRA collaborative project. Alcohol Clin Exp Res 2002; 26:332-339. (Pubitemid 34225837)
10. Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK, Vauthey JN, Charnsangavej C: Comparison of CT methods for determining the fat content of the liver. AJR 2007; 188:1307-1312. (Pubitemid 46668513)
11. Jacobs JE, Birnbaum BA, Shapiro MA, Langlotz CP, Slosman F, Rubesin SE, Horii SC: Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT. AJR 1998; 171:659-664.
12. Parés A, Deulofeu R, Giménez A, Cabaliería L, Bruguera M, Caballeria J, Balleste AM, Rodés J: Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 1996; 24:1399-1403.
13. Stickel F, Poeschl G, Schuppan D, Conradt C, Strenge-Hesse A, Fuchs FS, Hofmann WJ, Seitz HK: Serum hyaluronate correlates with histological progression in alcoholic liver disease. Eur J Gastroenterol Hepatol 2003; 15:945-950. (Pubitemid 37094292)
14. Lieber CS, Weiss DG, Paronetto F; Veterans Affairs Cooperative Study 391 Group: Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease. Alcohol Clin Exp Res 2008; 32:1031-1039. (Pubitemid 351733086)
15. Stewart S, Prince M, Bassendine M, Hudson M, James O, Jones D, Record C, Day CP: A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. J Hepatol 2007; 47:277-283. (Pubitemid 47021256)
16. Sánchez Pérez MJ, González-Reimers E, Santolana-Fernández F, et al.: Lipid peroxidation and serum cytokines in acute alcoholic hepatitis. Alcohol Alcohol 2006; 41:593-597. (Pubitemid 44742375)
17. Li YG, Ji DF, Chen S, Hu GY: Protective effects of sencin protein on alcohol-mediated liver damage in mice. Alcohol Alcohol 2008; 43:246-253. (Pubitemid 351695088)
18. Loguercio C, Federico A: Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med 2003; 34:1-10. (Pubitemid 36043881)